Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
602
+1
+0.2% +$356 0.04% 102
2025
Q4
$196K Buy
601
+12
+2% +$3.81K 0.04% 104
2025
Q3
$166K Sell
589
-13
-2% -$3.77K 0.04% 114
2025
Q2
$168K Buy
602
+390
+184% +$110K 0.04% 100
2025
Q1
$55K Hold
212
0.01% 185
2024
Q4
$55K Sell
212
-21
-9% -$6.23K 0.01% 185
2024
Q3
$74K Buy
233
+6
+3% +$1.96K 0.02% 146
2024
Q2
$70K Buy
227
+7
+3% +$2.06K 0.02% 139
2024
Q1
$63K Buy
220
+13
+6% +$3.8K 0.02% 146
2023
Q4
$60K Sell
207
-7
-3% -$1.91K 0.02% 145
2023
Q3
$57K Buy
214
+8
+4% +$2K 0.02% 146
2023
Q2
$44K Buy
206
+29
+16% +$6.73K 0.01% 171
2023
Q1
$46K Sell
177
-50
-22% -$12.3K 0.01% 151
2022
Q4
$51K Hold
227
0.02% 143
2022
Q3
$51K Hold
227
0.02% 144
2022
Q2
$55K Buy
227
+7
+3% +$1.72K 0.02% 132
2022
Q1
$53K Sell
220
-44
-17% -$10.1K 0.02% 124
2021
Q4
$59K Sell
264
-40
-13% -$8.44K 0.02% 117
2021
Q3
$65K Hold
304
0.02% 111
2021
Q2
$74K Sell
304
-18
-6% -$4.43K 0.02% 100
2021
Q1
$80K Hold
322
0.03% 87
2020
Q4
$74K Hold
322
0.02% 98
2020
Q3
$82K Hold
322
0.03% 68
2020
Q2
$76K Hold
322
0.03% 68
2020
Q1
$65K Buy
+322
New +$70.3K 0.03% 68

Other funds holding AMGN

Avion Wealth's AMGN Position: Q1 2026 in Review

Avion Wealth increased its Amgen (AMGN) stake by 0.17% in Q1 2026, buying an estimated $356 and bringing the position to 602 shares worth $211K. The position accounts for 0.04% of the portfolio, ranked #102.

Avion Wealth first reported a position in AMGN in Q1 2020 and has held it in 25 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Avion Wealth held 602 shares of Amgen worth $211K as of Q1 2026.
  • Avion Wealth bought 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.04% of Avion Wealth's portfolio in Q1 2026, its #102 holding.
  • Avion Wealth first reported a position in Amgen in Q1 2020 and has held it in 25 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.